Fungal-Driven Airways Dis-Immunity From Asthma to Allergic Bronchopulmonary Aspergillosis: Dissecting Similarities
Marco Caminati1,2, Isabella Annesi-Maesano3,4,5, Wojciech Feleszko6
1Allergy Unit and Asthma Center, Verona Integrated University Hospital, Verona, Italy.
Abstract:
Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) do not rarely coexist and share several similarities in terms of pathobiological background, together with overlapping clinical manifestations, misleading the correct diagnosis. Within that scenario, severe asthma with fungal sensitization (SAFS) further complicates the correct pheno-endotyping, which still needs to be recognized in the light of the greater burden and higher risk of irreversible damage related to ABPA and SAFS when compared to asthma alone. The identification of pathobiological drivers underlying different conditions remains challenging; in fact, available biomarkers, although accurate when related to each specific condition, do not always fully support a clear-cut differential diagnosis. The opportunity for innovative targeted treatments, although needing further evidence, should further stimulate a precise endo-phenotyping of severe asthma patients presenting some hallmarks of fungal-related dis-immunity to provide them the best standard of care for preventing disease evolution and achieving complete remission. This review provides a comparative outline of the recent advances in terms of pathophysiology, clinical manifestations, biomarkers, and management of asthma and ABPA, including a focus on SAFS, with the aim of updating the practical approach to those conditions and supporting their correct recognition.
Insights
Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) share similarities, complicating diagnosis. Recognizing severe asthma with fungal sensitization (SAFS) is crucial for better management and preventing irreversible damage.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Mycology
Background:
- Severe asthma and allergic bronchopulmonary aspergillosis (ABPA) frequently coexist, presenting overlapping symptoms and pathobiological drivers.
- Severe asthma with fungal sensitization (SAFS) further complicates accurate phenotyping, increasing disease burden and risk of irreversible lung damage.
Purpose of the Study:
- To provide a comparative overview of recent advances in understanding asthma, ABPA, and SAFS.
- To update the practical approach to diagnosing and managing these complex respiratory conditions.
- To highlight the need for precise endotyping for targeted treatments and improved patient outcomes.
Main Methods:
- Comparative review of pathophysiology, clinical manifestations, and biomarkers.
- Analysis of current diagnostic challenges and management strategies.
- Focus on differentiating fungal-related dis-immunity in severe asthma.
Main Results:
- Shared pathobiological backgrounds and clinical similarities between severe asthma and ABPA can mislead diagnosis.
- Biomarkers, while specific, may not always provide clear differential diagnoses.
- SAFS represents a significant challenge in phenotyping severe asthma patients.
Conclusions:
- Accurate recognition and pheno-endotyping of severe asthma, ABPA, and SAFS are essential for effective management.
- Further research into pathobiological drivers and innovative targeted treatments is warranted.
- Improved diagnostic strategies are needed to prevent disease progression and achieve remission.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Fungal Phylum Ascomycota
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...


